On 30 May, we hosted the webinar “Real-World Data in ALS”, in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective treatments and improved patient outcomes, this webinar aimed to shed light on the invaluable insights that RWD can provide.
Hosted by Lieza Exalto, Scientific Officer at Julius Clinical, this webinar featured Ruben van Eijk, Assistant professor at UMC Utrecht and TRICALS, and Mark van Dijk, Real World Evidence, Early Senior Strategy Lead, UCB Pharma, who discussed:
- Hybrid controlled clinical trials using concurrent registries in ALS: A feasibility study
- Use of real-world data in clinical drug development: An industry perspective
Watch the replay below:
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trials During this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed: Cognitive domains – which ones sho...
Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire Speakers: Dr. Sietske Sikkes | Associate Professor a...
On March 14, we presented, in collaboration with ECET, the webinar: The challenges within Epilepsy Trials in Europe During this webinar, guest speakers Prof. Jacqueline French, Prof. Alexis Arzimanoglou and Prof. Eugen Trinka discussed: –...